Regulus Therapeutics is a leading biopharmaceutical company specializing in the discovery and development of innovative RNA-targeted therapeutics. With a focus on harnessing the power of RNA interference (RNAi) and antisense oligonucleotide technologies, Regulus is at the forefront of advancing precision medicine for a wide range of diseases. The company's cutting-edge research and development efforts aim to revolutionize the treatment landscape by targeting specific genes and pathways to address unmet medical needs.

Refer new talent to Regulus Therapeutics